Eli Lilly is planning a $3.5 billion manufacturing plant in Pennsylvania, marking one of the largest life sciences investments ever made in the state.
The new facility will be built in Lehigh County and will focus on making injectable medicines and delivery devices, including treatments tied to the company’s fast-growing diabetes and weight-loss drugs. Construction is expected to begin in 2026, with the facility opening around 2031.
Lilly said the project will create about 850 full-time jobs once the plant is fully up and running, along with roughly 2,000 construction jobs during the buildout…